• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. VYPRO MESH UNKNOWN PRODUCT; MESH, SURGICAL, POLYMERIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. VYPRO MESH UNKNOWN PRODUCT; MESH, SURGICAL, POLYMERIC Back to Search Results
Catalog Number VYPROUNK
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hematoma (1884); Inflammation (1932); Seroma (2069); Urinary Retention (2119); Hypoesthesia (2352); Not Applicable (3189)
Event Type  Injury  
Manufacturer Narrative
(b)(4).This report is related to a journal article; therefore, no product will be returned for analysis and the batch history records cannot be reviewed as the lot number has not been provided.The single complaint was reported with multiple events.There are no additional details regarding the additional events.Citation: hernia (2004) 8: 127¿134 / doi 10.1007/s10029-003-0192-3.(b)(4).
 
Event Description
It was reported in a journal article with title: early results of a single-blinded, randomized, controlled, internet-based multicenter trial comparing prolene and vypro ii mesh in lichtenstein hernioplasty.The purpose of this single-blinded, randomized, controlled, internet-based multicenter trial was to compare a standard polypropylene mesh with the new polypropylene/polyglactin mesh in the lichtenstein operation.From dec 2000 to aug 2002, a total of 591 male patients, more than 25 years of age, with a unilateral primary inguinal hernia were eligible to participate in the study.The patients were randomized to lichtenstein¿s operation with either: prolene mesh group (n=295, mean age 54 years) or vypro ii mesh group (n=296, mean age 55 years).A piece of 7.5 x 15-cm prolene (ethicon) or vypro ii (ethicon) mesh was used according to the assigned group.Postoperative complications included prolonged postoperative pain or neuralgia (n=9, n=7 from prolene, n=2 from vypro ii); seroma (n=5, n=2 from prolene, n=3 from vypro ii); hematoma (n=25, n=11 from prolene, n=14 from vypro ii) which one patient needed reoperation with evacuation of the hematoma on the day of the operation under vypro ii group; urinary tract infection (n=1); testis atrofia (n=1); sensory loss (n=3, n=2 from prolene, n=1 from vypro ii); urinary retention (n=1); and ischemic orchitis (n=1).Lichtenstein¿s operation with either prolene or vypro ii is safe and well tolerated with an acceptable postoperative rehabilitation time and a high quality of life 2 months after surgery.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VYPRO MESH UNKNOWN PRODUCT
Type of Device
MESH, SURGICAL, POLYMERIC
Manufacturer (Section D)
ETHICON INC.
p.o. box 151, route 22 west
somerville NJ 08876 0151
Manufacturer (Section G)
ETHICON INC.-GMBH
robert-koch strasse 1
norderstedt 22851
GM   22851
Manufacturer Contact
darlene kyle
p.o. box 151, route 22 west
somerville, NJ 08876-0151
9082182792
MDR Report Key8915696
MDR Text Key155049472
Report Number2210968-2019-85928
Device Sequence Number1
Product Code FTL
Combination Product (y/n)N
Reporter Country CodeSW
PMA/PMN Number
K002672
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Other
Type of Report Initial
Report Date 07/30/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/21/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberVYPROUNK
Was Device Available for Evaluation? No
Date Manufacturer Received07/30/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-